See also stories tagged with Oncology
A team of researchers with Museum für Naturkunde and Charité—Universitätsmedizin, both in Germany, reports a case of a rare type of cancer in a 240-million-year-old stem-turtle fossil. In their paper published in JAMA Oncology, ...
Scientists from ITMO in collaboration with international colleagues have proposed new DNA-based nanomachines that can be used for gene therapy for cancer. This new invention can greatly contribute to more effective and selective ...
Herpes viral infections use the ancient genetic material found in the human genome to proliferate, mimicking the same process tumors have been found to manipulate, Mount Sinai researchers have shown for the first time. These ...
New York-based pharmaceutical giant Bristol-Myers Squibb on Thursday announced it would buy US biotech firm Celgene in a $74 billion cash-and-stock deal, creating a rival to the world's largest drug makers.
The importance of research into the role of the immune system in the development and therapy of oncological diseases was emphasized by the Royal Swedish Academy, which recently named James Allison and Tasuku Honjo recipients ...
New laboratory techniques can identify which of our genes are influenced by DNA snippets that are left behind in our genetic code by viruses, a new study finds.
The wonders of graphene are numerous—it can enable flexible electronic components, enhance solar cell capacity, filter the finest subatomic particles and revolutionize batteries. Now, the "supermaterial" may one day be used ...
Researchers from Charité - Universitätsmedizin Berlin have demonstrated on a molecular level how a specific protein allows light signals to be converted into cellular information. Their findings have broadened the understanding ...
Medical physicist Dr. Aswin Hoffmann and his team from the Institute of Radiooncology—OncoRay at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) have combined magnetic resonance imaging (MRI) with a proton beam, thus demonstrating ...
New accelerator-based technology being developed by the Department of Energy's SLAC National Accelerator Laboratory and Stanford University aims to reduce the side effects of cancer radiation therapy by shrinking its duration ...
